High-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in congenital coagulation disorders. A randomised, double-blind, placebo-controlled clinical trial

Autor:	Mmw Koopman, Karina Meijer, I. R. O. Novakova, P.J. Voogt, J.T.M. van der Meer, N.J.G.M. Veeger, J Schirm, W. M. Smid, E.P. Mausser-Bunschoten, F. W. G. Leebeek, M.C. Kappers-Klunne, Elizabeth B. Haagsma
Rok vydání:	2003
Předmět:	medicine.medical_specialty Hepatology business.industry Ribavirin Alpha interferon Placebo Gastroenterology Double blind Clinical trial chemistry.chemical_compound Chronic hepatitis chemistry Internal medicine Medicine business INDUCTION TREATMENT Coagulation Disorder
Zdroj:	Journal of Hepatology. 38:156-157
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(03)80805-x
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::914981f9502d565bb198769fc31c3da0 https://doi.org/10.1016/s0168-8278(03)80805-x Zobrazit plný text záznamu Full Text from ScienceDirect